Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celery Seed in Metabolic Syndrome
NCT06061926Phase 2Recruiting
- Sponsor
- Universidad de Guadalajara
- Start
- May 2023
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in metabolic syndrome comparing Celery Seed with Placebo (2 arms). Primary endpoints: Waist Circumference at 12 weeks, Systolic Blood Pressure at 12 weeks and 7 more. Started May 2023; status: recruiting.
02
Drugs
celery seed
03
Conditions
metabolic syndrome
Beyond the preview
Go deeper on NCT06061926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06061926.